China: A recent study published in Clinical Gastroenterology and Hepatology has highlighted the significant impact of type 2 diabetes (T2D) and long-term blood sugar management on the progression of metabolic dysfunction-associated steatotic liver disease (MASLD) . Led by Xiao-Dong Zhou and colleagues from the MASLD Research Center at Wenzhou Medical University, China, the research provides key insights into how glycemic control may influence liver health outcomes in patients with MASLD. The study analyzed data from 7,543 patients with MASLD participating in the VCTE-Prognosis cohort, who underwent serial vibration-controlled transient elastography (VCTE) assessments and hemoglobin A1c (HbA1c) measurements over a median follow-up of 4.1 years. Among these patients, 4,090 had T2

See Full Page